Azactam and Aspartate aminotransferase increased - a phase IV clinical study of FDA data

Summary:

Aspartate aminotransferase increased is reported as a side effect among people who take Azactam (aztreonam), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Diflucan, and have Bronchopulmonary aspergillosis.

The phase IV clinical study analyzes which people have Aspartate aminotransferase increased when taking Azactam. It is created by eHealthMe based on reports of 1,039 people who have side effects when taking Azactam from the FDA, and is updated regularly.

What is Azactam?

Azactam has active ingredients of aztreonam. eHealthMe is studying from 1,044 Azactam users. Check the latest studies of Azactam.

What is Aspartate aminotransferase increased?

Aspartate aminotransferase increased is found to be associated with 2,084 drugs and 3,385 conditions by eHealthMe. Check the latest studies of Aspartate aminotransferase increased.

On Aug, 01, 2026

1,039 people reported to have side effects when taking Azactam.
Among them, 36 people (3.46%) have Aspartate aminotransferase increased.

Could Azactam cause Aspartate aminotransferase increased?

Among these 36 people:

How long have people been on Azactam when they have Aspartate aminotransferase increased? *

What is the gender of people who have Aspartate aminotransferase increased when taking Azactam? *

female: 50 %
male: 50 %

What is the age of people who have Aspartate aminotransferase increased when taking Azactam? *

What are other drugs people take besides Azactam? *

What are other side effects people have besides Aspartate aminotransferase increased? *

Alanine Aminotransferase Increased: 24 people, 66.67%
Blood Bilirubin Increased: 16 people, 44.44%
Liver Disorder (liver diseases): 11 people, 30.56%
Blood Alkaline Phosphatase Increased: 11 people, 30.56%
Pneumonia: 10 people, 27.78%
Blood Urea Increased: 9 people, 25.00%
Hyperkalemia (damage to or disease of the kidney): 9 people, 25.00%
Weight Increased: 8 people, 22.22%
Acute Kidney Failure: 8 people, 22.22%
Antithrombin Iii Deficiency (rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism, and repetitive intrauterine fetal death (iufd)): 8 people, 22.22%

What are the existing conditions these people have? *

Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 8 people, 22.22%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 13.89%
Acute Kidney Failure: 3 people, 8.33%
Urinary Tract Infection: 3 people, 8.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 8.33%
Lung Adenocarcinoma Stage Iii (the cancer has spread to nearby tissue or too far away lymph nodes): 2 people, 5.56%
Candidiasis (candidiasis or thrush is a fungal infection): 2 people, 5.56%
Infection: 2 people, 5.56%
Sedation: 2 people, 5.56%
Pneumonia: 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Azactam and have Aspartate aminotransferase increased?

- Check whether Aspartate aminotransferase increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azactam:

Azactam (1,044 reports)

Browse all side effects of Azactam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aspartate aminotransferase increased:

Aspartate aminotransferase increased (2,084 drugs)

Browse all the conditions that are associated with Aspartate aminotransferase increased:

Aspartate aminotransferase increased (3,385 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aztreonam (the active ingredients of Azactam) and Azactam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.